Current liabilities increased 31.4%
Current liabilities changed +31.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed +31.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +27.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +24.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +27.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +37.7% from the comparable as-filed period.
Operating margin changed +315 basis points from the comparable as-filed period.
Revenue changed +24.8% from the comparable as-filed period.
Net income changed +42.7% from the comparable as-filed period.
Cash & equivalents changed +30.7% from the comparable as-filed period.
Gross profit changed +28.7% from the comparable as-filed period.
Operating cash flow changed +15.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +13.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed +153 basis points from the comparable as-filed period.
Trade receivables changed +33.2% from the comparable as-filed period.
Current long-term debt changed +71.3% from the comparable as-filed period.
Short-term borrowings changed +62.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory / revenue changed -751 basis points from the comparable as-filed period.
Receivables / revenue changed +533 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net debt changed -55.3% from the comparable as-filed period.
Research & development changed +22.1% from the comparable as-filed period.
Operating cash-flow margin changed -275 basis points from the comparable as-filed period.
Debt / revenue changed -1040 basis points from the comparable as-filed period.
Debt / assets changed -256 basis points from the comparable as-filed period.
Free-cash-flow margin changed -251 basis points from the comparable as-filed period.
Capital expenditure changed +21.1% from the comparable as-filed period.
Cash / debt changed +1355 basis points from the comparable as-filed period.
Operating cash flow / net income changed -19.2% from the comparable as-filed period.
Noncurrent long-term debt changed -4.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Inventory changed +13.0% from the comparable as-filed period.
Capex / revenue changed -24 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross debt changed +11.2% from the comparable as-filed period.
SBC / revenue changed -31 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed -0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Working capital / assets changed -73 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed +7.0% from the comparable as-filed period.
Current ratio changed -3.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -27 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.